BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8097788)

  • 1. Aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a controlled, randomized trial.
    Jensen BN; Nielsen TL; Backer V; Nelsing S; Simonsen L; Flaschs H; Gaub J; Højlyng N; Nielsen JO; Mathiesen L
    J Acquir Immune Defic Syndr (1988); 1993 May; 6(5):472-7. PubMed ID: 8097788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Torres RA; Barr M; Thorn M; Gregory G; Kiely S; Chanin E; Carlo C; Martin M; Thornton J
    Am J Med; 1993 Dec; 95(6):573-83. PubMed ID: 8018144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
    Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
    N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosolized pentamidine as primary prophylaxis for Pneumocystis carinii pneumonia: efficacy, mortality and morbidity.
    Lidman C; Berglund O; Tynell E; Lindbäck S; Elvin K
    AIDS; 1994 Jul; 8(7):935-9. PubMed ID: 7946102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An effectiveness community-based clinical trial of Respirgard II and Fisoneb nebulizers for Pneumocystis carinii prophylaxis with aerosol pentamidine in HIV-infected individuals. Toronto Aerosol Pentamidine Study (TAPS) Group.
    McIvor RA; Berger P; Pack LL; Rachlis A; Chan CK
    Chest; 1996 Jul; 110(1):141-6. PubMed ID: 8681618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis carinii infections in HIV-infected hemophiliacs during aerosolized pentamidine prophylaxis.
    Ewig S; Rockstroh JK; Seitz HM; Marklein G; Christ F; Lüchters G; Brackmann HH; Lüderitz B
    Respiration; 1993; 60(3):186-92. PubMed ID: 8210724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
    Hardy WD; Feinberg J; Finkelstein DM; Power ME; He W; Kaczka C; Frame PT; Holmes M; Waskin H; Fass RJ
    N Engl J Med; 1992 Dec; 327(26):1842-8. PubMed ID: 1448121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term administration of aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia in infants and children with symptomatic human immunodeficiency virus infection. The Italian Pediatric Collaborative Study Group on Pentamidine.
    Principi N; Marchisio P; Onorato J; Gabiano C; Galli L; Caselli D; Morandi B; Campelli A; Clerici M; Gattinara GC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):158-63. PubMed ID: 8680887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
    Carr A; Tindall B; Penny R; Cooper DA
    AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses.
    May T; Beuscart C; Reynes J; Marchou B; Leclercq P; Borsa Lebas F; Saba J; Micoud M; Mouton Y; Canton P
    J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):457-62. PubMed ID: 8158539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral pneumothoraces hasten mortality in AIDS patients receiving secondary prophylaxis with aerosolized pentamidine. Association with a lower Dco prior to receiving aerosolized pentamidine.
    Renzi PM; Corbeil C; Chassé M; Braidy J; Matar N
    Chest; 1992 Aug; 102(2):491-6. PubMed ID: 1643939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
    Mallolas J; Zamora L; Gatell JM; Miró JM; Vernet E; Valls ME; Soriano E; SanMiguel JG
    AIDS; 1993 Jan; 7(1):59-64. PubMed ID: 8442918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerosolized pentamidine prophylaxis against AIDS-related Pneumocystis carinii pneumonia and its short- and long-term effects on pulmonary function in the Japanese.
    Konishi M; Yoshimoto E; Takahashi K; Uno K; Kasahara K; Murakawa K; Maeda K; Mikasa K; Narita N
    J Infect Chemother; 2003 Jun; 9(2):178-82. PubMed ID: 12825119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Antinori A; Murri R; Ammassari A; De Luca A; Linzalone A; Cingolani A; Damiano F; Maiuro G; Vecchiet J; Scoppettuolo G
    AIDS; 1995 Dec; 9(12):1343-50. PubMed ID: 8605054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine.
    Köppen S; Grünewald T; Jautzke G; Gottschalk J; Pohle HD; Ruf B
    Clin Investig; 1992 Jun; 70(6):508-12. PubMed ID: 1356529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolized pentamidine versus i.v. pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia.
    Lidman C; Tynell E; Berglund O; Lindbäck S
    Infection; 1993; 21(3):146-9. PubMed ID: 8365811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased efficacy of inhaled pentamidine in the prevention of Pneumocystis carinii pneumonia among HIV-infected patients with severe immunodeficiency.
    Casale L; Gold H; Schechter C; Naficy A; Masci JR
    Chest; 1993 Feb; 103(2):342-4. PubMed ID: 8094333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.
    Hirschel B; Lazzarin A; Chopard P; Opravil M; Furrer HJ; Rüttimann S; Vernazza P; Chave JP; Ancarani F; Gabriel V
    N Engl J Med; 1991 Apr; 324(16):1079-83. PubMed ID: 2008181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Better efficacy of twice-monthly than monthly aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. An Italian multicentric randomised controlled trial. The Italian PCP Study Group.
    Rizzardi GP; Lazzarin A; Musicco M; Frigerio D; Maillard M; Lucchini M; Moroni M
    J Infect; 1995 Sep; 31(2):99-105. PubMed ID: 8666860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.